Lonza Group AG (SWX:LONN)
Switzerland · Delayed Price · Currency is CHF 562.20
-8.00 (-1.40%)
Jul 31, 2026, 5:30 PM CET
Lonza Group AG Financials Overview
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,329 | 6,531 | 5,480 | 6,717 | 6,223 | 5,409 |
Revenue Growth | -3.09% | 19.18% | -18.42% | 7.94% | 15.05% | 19.99% |
Gross Profit Gross Profit Growth | 2,312 | 2,309 | 1,793 | 1,948 | 2,438 | 2,110 |
Operating Income Operating Income Growth | 1,411 | 1,239 | 908 | 880 | 1,541 | 851 |
Net Income Net Income Growth | -110 | -275 | 636 | 654 | 1,215 | 2,944 |
Earnings Per Share EPS Growth | -1.54 | -3.93 | 8.92 | 8.88 | 16.34 | 39.52 |
EPS Growth | - | - | 0.45% | -45.66% | -58.65% | 239.81% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Integrated Biologics Integrated Biologics Growth | 3,706 | 3,649 | 2,883 | 3,719 | 3,274 | 2,699 |
Advanced Synthesis Advanced Synthesis Growth | 1,768 | 1,611 | 1,323 | 901 | 819 | 767 |
Specialized Modalities Specialized Modalities Growth | 1,113 | 1,034 | 1,099 | 696 | 693 | 602 |
Corporate Corporate Growth | 265 | 237 | 175 | 240 | 171 | 137 |
Revenue (Total) Revenue (Total) Growth | 6,329 | 6,531 | 5,480 | 6,717 | 6,223 | 5,409 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 487 | 719 | 1,711 | 1,668 | 2,224 | 3,184 |
Total Debt Total Debt Growth | 4,167 | 4,185 | 4,710 | 2,801 | 2,232 | 2,403 |
Net Cash (Debt) Net Cash Growth | -3,680 | -3,466 | -2,999 | -1,133 | -8 | 781 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -51.52 | -49.35 | -42.07 | -15.38 | -0.11 | 10.48 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,435 | 1,156 | 1,274 | 1,388 | 1,020 | 1,217 |
Capital Expenditures CapEx Growth | -1,228 | -1,321 | -1,381 | -1,653 | -1,830 | -1,301 |
Free Cash Flow Free Cash Flow Growth | 207 | -165 | -107 | -265 | -810 | -84 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.53% | 35.35% | 32.72% | 29.00% | 39.18% | 39.01% |
Operating Margin | 22.29% | 18.97% | 16.57% | 13.10% | 24.76% | 15.73% |
Pretax Margin | 20.29% | 16.86% | 12.92% | 11.76% | 23.27% | 14.05% |
Profit Margin | 17.14% | 13.92% | 10.99% | 9.75% | 19.57% | 12.52% |
FCF Margin | 3.27% | -2.53% | -1.95% | -3.95% | -13.02% | -1.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 4.000 | 4.000 | 3.500 | 3.000 |
Dividend Per Share Growth | 25.00% | 25.00% | 0% | 14.29% | 16.67% | 0% |
Dividend Yield | 0.89% | 0.75% | 0.76% | 1.01% | 0.68% | 0.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.34 | - | 60.07 | 39.83 | 27.73 | 19.27 |
Forward PE | 27.82 | 28.27 | 34.02 | 28.59 | 27.11 | 50.68 |
PS Ratio | 5.71 | 5.75 | 6.91 | 3.80 | 5.41 | 10.45 |